Kyle Fitzgerald

Project team leader with broad experience building and developing teams with a focus on multidisciplinary research projects. Fifteen years of experience in discovery, engineering and characterization of antibodies and antibody-drug conjugates. Passionate about turning data into compelling patient-centered stories. Looking for new exciting and vibrant opportunities.

My Expertise

Project Team Lead

Leading research projects, defining target product profiles (TPP), and collaborating with diverse stakeholders to drive programs forward.

Scientific Strategy & Leadership

Proven ability to build and lead multidisciplinary teams, define research priorities, and present to key stakeholders.

Antibody-Drug Conjugates (ADCs)

Leading ADC programs from proof-of-concept to IND-enabling studies, focusing on enhancing therapeutic potency and safety.

Biologics Discovery & Engineering

Extensive experience in engineering and evaluating monoclonal and bispecific antibodies for therapeutic applications.

Startup Experience

Thriving in fast-paced, dynamic startup environments, contributing across multiple functions to drive key projects forward.

Project & IP Management

Successfully managed research workstreams to support IP filings and guided late-stage research projects.

View Detailed Experience

Publications

Biparatopic antibodies: therapeutic applications and prospects.

Niquille, D. L., Fitzgerald, K. M., & Gera, N.

mAbs, 16(1), 2024
View Publication

Cited by 27
MYTX-011: A pH-Dependent Anti-c-MET Antibody-Drug Conjugate...

Gera, N., Fitzgerald, K. M., Ramesh, V., et al.

Molecular Cancer Therapeutics, 23(9), 2024
View Publication

Cited by 9
MYTX-011: A novel CMET-targeting antibody drug conjugate (ADC)...

Gera, N., Fitzgerald, K., Ramesh, V., et al.

AACR Annual Meeting 2023 [Poster]
View Poster

Cited by 5

Scientific Leader | Team Builder | Biologics | Antibody-Drug Conjugates